Studies of prostate cancer have shown increased marker expression of EMT and Notch1, including vimentin, N-cadherin, ZEB1 (Zinc-finger E-box binding homeobox), NF-κB, and PDGF-D in tumor cells [89]. The gene discussed is NOTCH1; the disease is neoplasm.